Recruiting
Phase 1

Brodalumab

Sponsor:

Brian Henick, MD

Code:

NCT06673329

Conditions

Breast Cancer

Esophageal Cancer

Kidney Cancer

Lung Cancer

Thyroid Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Brodalumab

CT scan

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-12. This information was provided to ClinicalTrials.gov by Brian Henick, MD on 2025-05-14.